Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
23/10/2023
0:00
19:54
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD.
Related Content:
Altri episodi di "JAMA Surgery Author Interviews"
Non perdere nemmeno un episodio di “JAMA Surgery Author Interviews”. Iscriviti all'app gratuita GetPodcast.